<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04004728</url>
  </required_header>
  <id_info>
    <org_study_id>LSR 0072/09</org_study_id>
    <nct_id>NCT04004728</nct_id>
  </id_info>
  <brief_title>Laser Treatment Of Leg Telangiectasias</brief_title>
  <official_title>Aavaliação do Tratamento de Telangiectasias Dos Membros Inferiores Com Laser 1064mm</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Sao Paulo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Sao Paulo</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Is 1064 nm YAG Laser better than sclerotherapy to treat leg veins?
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Comparison between laser and sclerotherapy in the treatment of telangiectasias of legs.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2010</start_date>
  <completion_date type="Actual">September 2011</completion_date>
  <primary_completion_date type="Actual">August 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>One leg laser ando the other sclerotherapy.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
    <masking_description>Blind photo evaluation.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Changes analysis after treatments of leg telangiectasias´clearance through photography using a scale of improvement.</measure>
    <time_frame>Analysis of photographic changes previous, and one week after treatment. Patient reanalysis after 1 and 3 months</time_frame>
    <description>Patients are asked about the best method to treat leg veins after three treatments of laser and three treatments of sclerotherapy. Evaluation of the photographic improvement of the treated areas on a scale of 0 (no improvement) to 10 (complete cleaning of the vessels).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes analysis after treatments of leg telangiectasias´clearance using a questionnaire to classify the pain</measure>
    <time_frame>1 week after treatment</time_frame>
    <description>Patients are asked about the best method to treat leg veins after three treatments of laser. All patients were asked to respond to a questionnaire classifying the pain (none, little, very painful or extremely painful).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes analysis after treatments of leg telangiectasias´clearance using a questionnaire to classify the cleaning of vessels</measure>
    <time_frame>1 week after treatment</time_frame>
    <description>Patients are asked about the best method to treat leg veins after three treatments of laser. All patients were asked to respond to a questionnaire classifying the cleaning of vessels (poor, regular, good or excellent)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes analysis after treatments of leg telangiectasias´clearance using a questionnaire to classify the satisfaction with results</measure>
    <time_frame>1 week after treatment</time_frame>
    <description>Patients are asked about the best method to treat leg veins after three treatments of laser. All patients were asked to respond to a questionnaire classifying satisfaction with results (nothing, little or much</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Leg Veins</condition>
  <arm_group>
    <arm_group_label>laser, leg veins, sclerotherapy</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>to compare laser and sclerotherapy on treating leg veins</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>1064 Nd:YAG laser</intervention_name>
    <description>1064 laser - 135J 25ms spot 3mm GLicose - 75% - 3 ml</description>
    <arm_group_label>laser, leg veins, sclerotherapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients with leg telangiectasias

        Exclusion Criteria:

          -  varicose veins

          -  DVT

          -  pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nelson Wolosker, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Hospital das Clinicas, University of Sao Paulo</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Vascular Surgery HCFMUSP</name>
      <address>
        <city>Sao Paulo</city>
        <zip>04534000</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>September 21, 2011</study_first_submitted>
  <study_first_submitted_qc>June 27, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 2, 2019</study_first_posted>
  <last_update_submitted>June 27, 2019</last_update_submitted>
  <last_update_submitted_qc>June 27, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 2, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Sao Paulo</investigator_affiliation>
    <investigator_full_name>Nelson Wolosker</investigator_full_name>
    <investigator_title>Principal Investigator, Associate Professor, MD, PhD</investigator_title>
  </responsible_party>
  <keyword>laser</keyword>
  <keyword>telangiectasias</keyword>
  <keyword>leg veins</keyword>
  <keyword>sclerotherapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Telangiectasis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

